These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38501355)

  • 41. Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals.
    Liu X; Boothe DM; Thungrat K; Aly S
    Vet Microbiol; 2012 Dec; 161(1-2):159-68. PubMed ID: 22877517
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CTX-M-producing
    Giedraitiene A; Pereckaite L; Bredelyte-Gruodiene E; Virgailis M; Ciapiene I; Tatarunas V
    Future Microbiol; 2022 Jul; 17():789-802. PubMed ID: 35549350
    [No Abstract]   [Full Text] [Related]  

  • 43. In vitro Temocillin efficacy against extended spectrum β-lactamase producing multidrug resistant gram negative bacterial isolates from Nepal.
    Kandel BP; Bhatta DR; Shakya G; Upadhayay BP; Dumre SP; Poudyal S; Adhikari N; Acharya D
    Nepal Med Coll J; 2014 Dec; 16(2-4):144-7. PubMed ID: 26930733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection.
    Pourbaix A; Guérin F; Lastours V; Chau F; Auzou M; Boulley E; Cattoir V; Fantin B
    Int J Med Microbiol; 2017 Dec; 307(8):452-459. PubMed ID: 28986014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alternatives to carbapenems in ESBL-producing Escherichia coli infections.
    Fournier D; Chirouze C; Leroy J; Cholley P; Talon D; Plésiat P; Bertrand X
    Med Mal Infect; 2013 Feb; 43(2):62-6. PubMed ID: 23433608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural Alteration of OmpR as a Source of Ertapenem Resistance in a CTX-M-15-Producing Escherichia coli O25b:H4 Sequence Type 131 Clinical Isolate.
    Dupont H; Choinier P; Roche D; Adiba S; Sookdeb M; Branger C; Denamur E; Mammeri H
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibacterial activity of temocillin.
    Malottke R; Potel J
    Drugs; 1985; 29 Suppl 5():67-73. PubMed ID: 3849426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.
    Vingopoulou EI; Siarkou VI; Batzias G; Kaltsogianni F; Sianou E; Tzavaras I; Koutinas A; Saridomichelakis MN; Sofianou D; Tzelepi E; Miriagou V
    J Antimicrob Chemother; 2014 Aug; 69(8):2076-80. PubMed ID: 24722836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and Pharmacodynamics of Temocillin.
    Alexandre K; Fantin B
    Clin Pharmacokinet; 2018 Mar; 57(3):287-296. PubMed ID: 28849402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activity of temocillin against CTX-M-producing Escherichia coli and Klebsiella pneumoniae from Germany.
    Kresken M; Körber-Irrgang B; Pfeifer Y; Werner G
    Int J Antimicrob Agents; 2018 Jan; 51(1):159-160. PubMed ID: 28705669
    [No Abstract]   [Full Text] [Related]  

  • 51. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
    Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT
    Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of 1-(1-naphthylmethyl)-piperazine on antimicrobial agent susceptibility in multidrug-resistant isogenic and veterinary Escherichia coli field strains.
    Marchetti ML; Errecalde J; Mestorino N
    J Med Microbiol; 2012 Jun; 61(Pt 6):786-792. PubMed ID: 22345599
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Zhou YF; Tao MT; He YZ; Sun J; Liu YH; Liao XP
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Microbiological studies with the new penicillin BRL 17421 (temocillin)].
    Malottke R; Potel J
    Infection; 1983; 11(1):47-51. PubMed ID: 6302007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The accessibility of cross-reactive anti-lipopolysaccharide-core monoclonal antibodies to Escherichia coli grown in sub-MICs of temocillin and other antibiotics.
    Edmond DM; Poxton IR; di Padova F
    J Antimicrob Chemother; 1993 May; 31(5):673-80. PubMed ID: 8335496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Rising Tide of Antibiotic Resistance: A Study on Extended-Spectrum Beta-Lactamase and Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae.
    Ejaz H; Qamar MU; Farhana A; Younas S; Batool A; Lone D; Atif M; Alruways MW; Alruwaili M; Hamad I; Selim S; Mazhari BBZ; Farooq A; Junaid K
    J Clin Lab Anal; 2024 May; 38(10):e25081. PubMed ID: 38884333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Temocillin against Enterobacteriaceae isolates from community-acquired urinary tract infections: low rate of resistance and good accuracy of routine susceptibility testing methods.
    Alexandre K; Réveillon-Istin M; Fabre R; Delbos V; Etienne M; Pestel-Caron M; Dahyot S; Caron F
    J Antimicrob Chemother; 2018 Jul; 73(7):1848-1853. PubMed ID: 29635629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal Peptidase.
    Pantua H; Skippington E; Braun MG; Noland CL; Diao J; Peng Y; Gloor SL; Yan D; Kang J; Katakam AK; Reeder J; Castanedo GM; Garland K; Komuves L; Sagolla M; Austin CD; Murray J; Xu Y; Modrusan Z; Xu M; Hanan EJ; Kapadia SB
    mBio; 2020 Sep; 11(5):. PubMed ID: 32900806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-HIV agent azidothymidine decreases Tet(X)-mediated bacterial resistance to tigecycline in Escherichia coli.
    Liu Y; Jia Y; Yang K; Li R; Xiao X; Wang Z
    Commun Biol; 2020 Apr; 3(1):162. PubMed ID: 32246108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.